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Abstract Stroke is a major cause of mortality and long-
term disability worldwide. The initial changes in local
perfusion and tissue status underlying loss of brain function
are increasingly investigated with noninvasive imaging
methods. In addition, there is a growing interest in imaging
of processes that contribute to post-stroke recovery. In this
review, we discuss the application of magnetic resonance
imaging (MRI) to assess the formation of new vessels by
angiogenesis, which is hypothesized to participate in brain
plasticity and functional recovery after stroke. The excel-
lent soft tissue contrast, high spatial and temporal resolu-
tion, and versatility render MRI particularly suitable to
monitor the dynamic processes involved in vascular
remodeling after stroke. Here we review recent advances in
the ﬁeld of MR imaging that are aimed at assessment of
tissue perfusion and microvascular characteristics, includ-
ing cerebral blood ﬂow and volume, vascular density, size
and integrity. The potential of MRI to noninvasively
monitor the evolution of post-ischemic angiogenic pro-
cesses is demonstrated from a variety of in vivo studies in
experimental stroke models. Finally, we discuss some pit-
falls and limitations that may critically affect the accuracy
and interpretation of MRI-based measures of (neo)vascu-
larization after stroke.
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Introduction
Stroke is the result of occlusion or rupture of a brain artery,
leading to loss of focal blood ﬂow and brain function.
Despite signiﬁcant neurological deﬁcits, most patients
experience at least some degree of spontaneous recovery
[1], which may be augmented by therapeutic intervention
[2]. Currently, neuroprotective therapy after acute clinical
stroke is restricted to the use of a single therapeutic agent,
recombinant tissue plasminogen activator (rtPA), which
should be given within 4.5 h after stroke to limit risk of
hemorrhagic transformation [3]. However, experimental
studies suggest that restorative pharmacological and cell-
based therapies have potential to improve functional out-
come when initiated 24 h up to weeks after stroke [2]. Such
therapies amplify certain endogenous processes, some of
which are also activated in the developing brain [4], that
may contribute to spontaneous recovery after stroke. These
events not only involve neuronal reorganization, but also
include vascular remodeling through angiogenesis. Inter-
estingly, there is an increasing amount of studies that has
provided evidence for formation of new blood vessels after
cerebral ischemia, and a possible signiﬁcant role of angi-
ogenesis in post-stroke recovery [5–10]. However, the
exact pattern of neovascularization and its relation to res-
toration of function after stroke are still largely unresolved.
Therefore, thorough characterization of the spatial and
temporal proﬁle of angiogenesis after ischemic stroke is of
signiﬁcant importance to elucidate its role in recovery and
remodeling of neuronal tissue and ensuing functional
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development of neurorestorative therapies.
Magnetic resonance imaging (MRI) provides a powerful
tool to noninvasively assess the evolution of various indi-
ces that can characterize cerebral tissue status after stroke
[11–14]. Over the last decade, different MRI methods have
also been applied to measure angiogenesis-related pro-
cesses. This review describes results from such studies in
experimental stroke models and discusses the principles,
potentials and pitfalls of MRI methods to assess brain
angiogenesis after stroke. First, the physiological process
of angiogenesis after stroke will be brieﬂy introduced. The
main emphasis will be on the methodology and application
of different MR imaging techniques, with and without
contrast enhancement, that enable noninvasive monitoring
of developing and mature microvasculature for stroke
research.
Angiogenesis after stroke
Angiogenesis is the formation of new blood vessels from
existing vessels, which is a normal and vital process in
tissue growth and development that may also occur under
pathophysiological conditions, such as after stroke. The
physiological cascade of angiogenesis after stroke is highly
complex and has already been extensively described in
recent reviews [5, 6, 8–10]. Here we restrict the description
of post-stroke angiogenesis to a brief introduction of the
stages of onset, formation and maturation of new blood
vessels (schematically illustrated in Fig. 1). We refer to the
above reviews and references therein for more detailed
explanation of the molecular and cellular aspects of angi-
ogenesis after stroke.
Upon cessation of blood ﬂow, the hypoxic/ischemic
condition around a stroke lesion rapidly triggers tran-
scription of a variety of genes that may be involved in the
process of angiogenesis [6]. For example, the production of
polypeptide growth factors, such as vascular endothelial
growth factor (VEGF), and proinﬂammatory cytokines by
residing brain cells and/or inﬁltrating inﬂammatory cells,
creates a permissive environment for sprouting of prolif-
erating endothelial cells [6, 8, 10]. It has been shown in
rodent stroke models that proliferating endothelial cells
form vascular buds that connect with small microvessels a
few days after stroke (Fig. 2a–c). This stage of early
angiogenesis is associated with a highly leaky blood–brain
barrier (BBB) [15, 16]. From 1 week after stroke, signiﬁ-
cant increases in microvessel density have been reported
[8]. With time of survival, the conglomerates of micro-
vessels increase in size (Fig. 2d), potentially giving rise to
an increased cerebral blood volume (CBV) and ﬂow (CBF)
[17, 18]. Furthermore, a decrease in vessel permeability
can be seen over time [8], which is suggestive for remod-
eling of pericytes, astrocytes and other cells that are
involved in BBB integrity.
Importantly, formation of new vessels after stroke may
(1) contribute to recovery of tissue-at-risk by restoring
metabolism in surviving neurons, (2) facilitate removal of
necrotic debris, and/or (3) enhance supply of neurotrophic
compounds for neuronal remodeling (e.g. synaptogenesis
and neurite sprouting) [5, 6, 8–10, 19]. However, whether
angiogenesis indeed gives rise to full-ﬂedged functional
vascular networks around a stroke lesion is still unclear and
remains an important topic for further research.
MRI-based assessment of brain angiogenesis
after stroke
Inthelasttwodecades,MRIhasproven tobeavaluabletool
to investigate the spatiotemporal proﬁle of ischemia-
induced changes after stroke, mainly attributable to its
capability to longitudinally evaluate a wide spectrum of
structural and functional tissue characteristics. This versa-
tility originates from the fact that contrast in MR images is
dependent on intrinsic, biophysical tissue properties such as
proton density, inter- and intramolecular magnetic interac-
tions, oxygenation state, magnetic susceptibility, diffusion,
perfusion and ﬂow. These endogenous tissue characteristics
inﬂuence the MRI signal by their effect on MR relaxation
times (T1, T2 and T2
*) and water proton mobility, which can
be exploited to generate image contrast. Additionally,
exogenous contrast agents (e.g. gadolinium chelates and
Fig. 1 Schematic representation of the cascade of events associated
with angiogenesis after ischemic stroke. The physiological phenom-
ena on the left side may be assessed with MRI (BBB blood–brain
barrier, MVD microvessel density, CBV cerebral blood volume, CBF
cerebral blood ﬂow)
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123iron oxide particles) can be applied to enhance endogenous
contrast-generating mechanisms. This can improve ana-
tomical and/or physiological distinction, and may allow
detection of otherwise indiscernible factors. In stroke
research, both endogenous and exogenous MR contrast
mechanisms have been exploited to assess cerebrovascular
changes associated with angiogenesis. In the following
sections the various MR imaging techniques that have been
utilized to assess angiogenesis in the brain will be reviewed.
MRI of vessels, blood volume and perfusion
Probably the most intuitive way to evaluate the presence of
angiogenic vessels is direct visualization of the newly
formed vasculature by MR angiography [20]. However, the
spatial resolution of MRI is currently limited to approxi-
mately 50 lm for small animal MR imaging, and to
approximately 250 lm on clinical MRI scanners. Since
angiogenic processes in brain tissue, such as endothelial
sprouting and microvessel formation, take place at length
scales that are at least one order of magnitude lower, direct
depiction of remodeling of cerebrovascular structures is
currently not feasible with MRI. Alternatively, hemody-
namic parameters that are directly affected by angiogenesis,
such as cerebral blood volume (CBV) and cerebral blood
ﬂow (CBF), can be measured with perfusion MR imaging
techniques such as dynamic susceptibility contrast-
enhanced (DSC-)MRI, steady state susceptibility contrast-
enhanced (ssCE-)MRI and arterial spin labeling (ASL).
DSC- and ssCE-MRI are based on detection of signal
changes induced by intravascularly injected exogenous
contrast agents, while ASL exploits endogeneous contrast
mechanisms involving magnetically labeled arterial water.
The following paragraphs provide a brief introduction to
these MRI methods. For more detailed information on the
principles of the different perfusion MRI techniques, we
refer the reader to speciﬁc reviews [21–23].
Dynamic susceptibility contrast-enhanced MRI
DSC-MRI allows calculation of cerebral hemodynamic
parameters from the time-course of signal changes induced
by the ﬁrst passage of a paramagnetic contrast agent after
intravenous injection [24]. The most commonly applied
exogenous contrast agents are gadolinium chelates [25].
Their high magnetic susceptibility induces local magnetic
ﬁeld inhomogeneities. The consequent local shortening of
T2 and T2
* leads to enhanced MR signal decay. By
dynamically monitoring these signal changes in perfused
tissue during the ﬁrst passage of a bolus of injected contrast
agent, hemodynamic parameters such as CBF, CBV
and mean transit time (MTT) can be estimated from the
linear relationship between contrast agent concentration
and change in effective transverse relaxation rate
(DR2
* = D(1/T2
*), and the central volume theory [24, 25].
DSC-MRI has been successfully applied for spatiotem-
poral monitoring of changes in CBV in relation to
Fig. 2 Scanning electron
micrographs of vascular casts of
rat brains after unilateral
occlusion of the middle cerebral
artery (MCA). Three days after
MCA occlusion, vascular
budding was visible at many
sites in the ipsilateral cortex,
involving both small and large
vessels (a white arrows).
Microvessels formed
connections with surrounding
proliferating vessels (b, c white
arrows). With time of survival,
the conglomerates of
microvessels increase in size,
forming a dense and chaotic
microvasculature surrounding
larger microvessels (d). Inserted
bars denote the magniﬁcation in
each ﬁgure. Reproduced from
Ref. [77] with permission from
Lippincott, Williams and
Wilkins
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123formation of new blood vessels in brain tumors, where a
signiﬁcant correlation was found between increase of rel-
ative CBV and histologically determined microvessel
density and fractional blood volume [26]. In a rat stroke
model, Lin et al. demonstrated with DSC-MRI that CBV
was signiﬁcantly enhanced in the ipsilateral cerebral cortex
at 7 days after transient unilateral occlusion of the middle
cerebral artery (MCA), which correlated with increased
vessel density in the outer cortical layer [18]. Similarly,
DSC-MRI has been applied to measure changes in CBV in
a rat embolic stroke model after angiogenesis-promoting
treatment with neuronal progenitor cells [27]. A coincident
increase of CBV and vascular density was reported, sug-
gesting a relationship between the elevated CBV and
angiogenesis [27].
Arterial spin labeling
As mentioned above, CBF can also be determined with MRI
without the use of exogenous contrast agents. In ASL,
radiofrequency (RF) pulses are used to magnetically alter
the status of water protons in arterial blood with respect to
those in stationary tissue water, thereby generating an
endogenous intravascular tracer [28, 29]. Assuming that the
magnetically labeled arterial blood exchanges with tissue
water at the level of the capillaries, CBF can in principle be
quantiﬁed from a labeling experiment and a control exper-
iment without magnetically labeled water protons, based on
the theory of diffusible tracer kinetics [28, 30, 31].
ASL has been applied in a number of experimental
stroke studies to estimate CBF in relation to angiogenesis.
In conjunction with an increased vascular density, which is
clearly visible on the surface of the ipsilateral brain surface
in Fig. 3a, Lin et al. demonstrated a signiﬁcantly enhanced
CBF in the perilesional cortex from day 1 to 14 after
transient MCA occlusion in rats (Fig. 3b, c) [18]. Chopp
and co-workers have reported that treatment with the va-
sodilatator sildenaﬁl enhanced angiogenesis and selectively
increased the CBF level in the ischemic boundary in rats
after embolic stroke [17, 32]. Furthermore, co-localization
of the area with CBF improvement with regions with
increased fractional anisotropy of white matter tissue was
reported, pointing towards a link between angiogenesis and
neuronal reorganization [32, 33].
Despite the signiﬁcant information on tissue perfusion,
MRI-based measurement of hemodynamics provides rela-
tively low speciﬁcity for angiogenesis. For example, CBV
and CBF increases may also arise in response to autoreg-
ulatory vasodilation or vessel recruitment due to arterio-
genesis. Therefore, alternative MR methodologies that
allow assessment of structural features of the microvascu-
lature that may be more speciﬁcally related to angiogenesis
have been recently proposed, which will be the subject of
the following paragraph.
Steady state susceptibility contrast-enhanced MRI
As opposed to measurement of tissue perfusion from the
dynamics of MR signal decay due to ﬁrst passage of a
contrast agent in DSC-MRI, ssCE-MRI allows estimation
of blood volume, microvessel density and vessel size from
steady state contrast-induced signal changes. In ssCE-MRI,
Fig. 3 Longitudinal changes in
vascular density and CBF after
60 min of transient MCA
occlusion in rats. Excised rat
brains clearly show enhanced
vascular density on the cortical
surface of the ipsilateral
hemisphere after MCA
occlusion (a). Relative CBF
maps (b) calculated from ASL
experiments demonstrate a
signiﬁcantly increased CBF in
the ipsilateral cortex from day 1
up to day 14 after MCA
occlusion (c). Reproduced from
Ref. [18] with permission from
Lippincott Williams and
Wilkins
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123transverse relaxation rates R2 and R2
* are measured before
and after administration of an intravascular contrast agent
that establishes a high susceptibility difference, for quan-
titative purposes [34], and has a long blood half-life, for a
prolonged acquisition time-window [35–37]. To that aim,
ultrasmall superparamagnetic iron oxide (USPIO) particles
have been most frequently applied [23]. The long circu-
lating USPIOs generate a static magnetic ﬁeld inhomoge-
neity around the vessels. Such ﬁeld inhomogeneities affect
spin echo and gradient echo transverse relaxation rates (R2
and R2
*, respectively) in a different way, dependent on
many factors including concentration and susceptibility of
the contrast agent, vessel diameter, fractional blood vol-
ume, tissue diffusion coefﬁcient, magnetic ﬁeld strength
and MR imaging protocol (see references [38–41] for
detailed MR physical background information on intra-
vascular susceptibility contrast mechanisms). With math-
ematical modeling and Monte Carlo simulations it has been
shown that changes in the transverse relaxation rate R2 (i.e.
DR2), as a result of the application of an intravascular
susceptibility contrast agent, are predominantly sensitive to
small vessels (\10 lm), while changes in the transverse
relaxation rate R2
* (i.e. DR2
*) are sensitive to vessels of all
sizes [34, 38–42]. This sensitivity of DR2 for small vessels
was exploited by Dunn et al. to enable quantiﬁcation of the
CBV increase associated with hypoxia-induced angiogen-
esis in rat brain, based on measurements of DR2 in brain
parenchyma and serum, and a veriﬁed linear dependence
between DR2 and contrast agent concentration [43]. When
the local DR2
* and susceptibility difference (Dv) are known,
it has been shown from theory and simulations that the total
blood volume fraction (BVf) can be estimated from the
following equation [40, 41, 44].
BVf ¼ 3=4ðpÞDR 
2=ðcDvB0Þð 1Þ
In rat brain tumors, blood volume fractions determined
using Eq. 1 were shown to correlate reasonably well with
histological measurements [45, 46].
Beside estimation of blood volume, ssCE-MRI can pro-
vide speciﬁc details on vascular morphology. Dennie et al.
have demonstrated that the ratio of the change in R2
* and R2
before and after contrast agent injection, i.e. DR2
*/DR2,
directly relates to microvessel morphology [47], as had
originally been predicted based on mathematical modeling
[38]. A signiﬁcant correlation between an increase of the
DR2
*/DR2 ratio and an increase of the average histological
vessel diameter was observed inside tumor tissue [47],
which was attributed to enlarged diameters of angiogenic
vessels [44–47]. Tropres et al. further developed this con-
cept of vessel size imaging based on steady state contrast-
enhanced relaxation rate shifts [44, 48], and deﬁned the
vessel size index (VSI), a measure of the average vessel
radius [48].
VSIðlmÞ¼0:425ðD=cDvB0Þ
1=2ðDR 
2=DR2Þ
3=2 ð2Þ
Although good correlations between VSI and the
histological vessel size have been reported [44],
calculations of VSI have been based on estimations of
the intravascular susceptibility difference (Dv) before and
after injection of contrast agent, and the local diffusion
coefﬁcient (D)[ 34, 48, 49]. Since Dv is difﬁcult to
determine under most in vivo conditions, Jensen and
Chandra introduced the ratio Q : DR2/(DR2
*)
2/3, which for
a sufﬁciently high Dv, only depends on intrinsic tissue
properties, and which should correlate with microvessel
density (MVD) [49].
MVDðmm 2Þ Q3=ð4:725DÞð 3Þ
Wu et al. have assessed the MVD in normal mouse brain
based on the ratio Q, using a literature value for
D = 0.664 lm
2/ms [50]. This provided an average brain
MVD of 282 ± 43/mm
2, which is in reasonable agreement
with histologically determined values.
Recently, two studies have employed ssCE-MRI to
assess vascular remodeling after experimental stroke [51,
52]. In a serial study in rats recovering from transient
cerebral ischemia performed by Lin et al., an initial
decrease in vascular density (based on the Q value) and an
increase in vessel size (based on VSI) was observed in the
reperfused cortex at day 1 and 3 [52]. Immunohistological
analysis conﬁrmed a similar decrease in microvessel den-
sity and increase in size of vessels with a diameter larger
than 30 lm. These observations were explained by a more
pronounced effect of edema on compression of small
capillaries as compared to large-sized vessels, leading to a
shift in the calculated average vessel size. A signiﬁcant
increase of total CBV from day 3 to 14 in the affected
hemisphere, based on DR2
*, was speculated to be caused by
improvement of collateral circulation in the relatively large
microvessels. At days 14 and 21, increases in DR2
(microvascular CBV) and Q (microvascular density) were
noticed in the reperfused cortex, which was attributed to
the surge of angiogenesis. In contrast, Bosomtwi et al.
observed a lowered Q-based and histology-based MVD in
recovered ischemic tissue at 2 weeks after embolic stroke
in rats [51]. A possible explanation is that only a small part
of the recovered region was highly angiogenic, which may
have been obscured by the analysis of a relatively large
region-of-interest [51].
The potential of ssCE-MRI to monitor changes in CBV,
microvessel density and vessel size in a single experiment,
is demonstrated in Fig. 4. We performed ssCE-MRI in rats
at 7 days after 60 min transient unilateral MCA occlusion.
R2 and R2
* maps were acquired pre- and post-administration
of 16.5 mg/kg USPIO (Guerbet, Aulnay-sous-Bois,
France). Figure 4 shows exemplary data from a rat with a
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123subcortical infarct. The pre-contrast R2 map clearly depicts
a unilateral lesion in the caudate putamen, characterized by
a decreased R2 value, i.e. prolonged T2, associated with
vasogenic edema [13] (Fig. 4a). A hyperintense spot in the
center of the lesion, which also revealed a high R2
* value on
the pre-contrast R2
* map (Fig. 4b), corresponded with a
bleeding identiﬁed with histology (Fig. 4g). The increased
R2
(*) can be explained by accumulation of paramagnetic
deoxygenated blood [53]. The DR2
* value (Fig. 4d), directly
related to total BVf (Eq. 1), was increased in the lesion as
compared to the contralateral hemisphere, suggestive of
hyperperfusion. The ipsilateral hypothalamic region dis-
played an elevated DR2 (Fig. 4c), which also revealed a
high Q value (Fig. 4f), suggestive of an enhanced micro-
vascular CBV and microvessel density, respectively. These
ﬁndings are in agreement with results presented by Lin
et al. [52] as discussed in the previous paragraph. The
relatively high pre-contrast R2
* value in this region may
have been caused by an enhanced venous blood volume, as
was suggested by Ding et al. [33], which will be further
elaborated on in the next section. The DR2
*/DR2 map shows
a low value in this area, pointing toward a low average
vessel size (Fig. 4e). In contrast, a high DR2
*/DR2 value was
observed in the remaining part of the lesion, which sug-
gests that the average vessel size was relatively high.
Histology conﬁrmed substantial presence of larger vessels
in the lesion (Fig. 4g1), as well as an increased microvessel
density (Fig. 4g4) in the area with a high Q value. Con-
tralaterally, normal vessel size (Fig. 4g2) and densities
(Fig. 4g5) were observed. Perls’ Prussian Blue staining
conﬁrmed that USPIO had not extravasated (data not
shown).
Fig. 4 MRIandhistologyofacoronalratbrainsliceat7 daysafter60-
min unilateral MCA occlusion, resulting in a subcortical infarct. Pre-
contrast R2 map displays the subcortical lesion with decreased R2 (a).
The hyperintense spot inside the lesion on the pre-contrast R2 and R2
*
maps reﬂects a bleeding (a and b). The enhanced R2
* in the ipsilateral
hypothalamus may be a sign of increased venous blood volume (b).
This area exhibited an increased DR2 value after administration of a
superparamagnetic blood pool agent (USPIO), pointing toward an
increase in the density of microvessels with a relatively small diameter
(c). The high contrast-induced DR2
* in the entire lesion is reﬂective of
increased total blood volume (d). The high DR2
*/DR2 ratio in the lesion
is indicative of a relatively large vessel diameter (e), as was conﬁrmed
by histology with vessel staining with von Willebrand Factor (DAB-
enhanced; brown) (nuclei were stained with hematoxylin (blue)) (g1).
The ipsilateral hypothalamic region exhibited a low value on the DR2
*/
DR2 map, indicating a low vessel diameter. A high Q value was
observed in this area (f), indicative of an enhanced MVD, which was
conﬁrmed by histology (g4). Contralaterally, normal vessel size (g2)
and density (g5) were observed (R2,R2
*, DR2 andDR2
* are in units sec
-1,
Q is in units sec
-1/3)
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123MRI of blood–brain barrier permeability and tissue
oxygenation
Next to assessment of hemodynamic and morphologic
changes related to vascular remodeling, MRI can provide
information on BBB permeability and oxygenation state of
brain tissue, which both are involved in the process of
angiogenesis. BBB permeability can be investigated by
dynamic contrast-enhanced MRI (DCE-MRI), in which
changes in MR signal, as a result of leakage of an intra-
vascularly injected contrast agent into the interstitial space,
are dynamically monitored [54]. The oxygenation state of
brain tissue can be investigated by exploiting the high
magnetic susceptibility of deoxygenated hemoglobin [55].
Since venous blood is rich of deoxygenated hemoglobin,
blood oxygenation level-dependent (BOLD) MRI may
detect newly developed vasculature that is rich of venous
blood [33]. Both methods will be brieﬂy introduced in
relation to their potential to evaluate angiogenesis after
stroke.
Dynamic contrast-enhanced MRI
DCE-MRI measures the time-course of contrast-induced
changes of the T1 relaxation time constant due to contrast
agent extravasation into tissue. Since the tissue T1 is
directly related to the intravascular and parenchymal con-
centration of the contrast agent, one can estimate the blood-
to-brain transfer constant, Ki, by locally assessing the
dynamics of the signal intensity of a time-series of T1-
weighted MR images, or T1 maps, with tracer kinetic
models [54, 56, 57]. In experimental stroke research, DCE-
MRI with gadolinium chelates has been employed to
quantify BBB integrity [16, 17, 27, 33, 52, 58–61]. BBB
breakdown develops within hours after the onset of brain
ischemia [16, 58, 62], which has been associated with a
variety of pathophysiological processes, including the ini-
tial inﬂammatory response and upregulation of the vascular
permeability factor VEGF [10, 63]. Interestingly, a sig-
niﬁcant increase of Ki has been observed with DCE-MRI at
later time points after stroke as well, which has been
hypothesized to be associated with angiogenesis [17, 27,
33, 52, 59]. Chopp and co-workers have reported that Ki
peaks around 2 weeks after experimental stroke, coincident
with increases in CBF, CBV and vessel density in the same
regions, and they have proposed Ki as an additional marker
for angiogenesis [27, 59]. Experimental angiogenesis-pro-
moting treatment with sildenaﬁl was reported to accelerate
the dynamics of the BBB leakage [33] (Fig. 5).
Blood oxygenation level-dependent MRI
With BOLD MRI, the local magnetic ﬁeld disturbances
induced by the relatively high magnetic susceptibility of
deoxygenated hemoglobin are exploited, which provides T2
contrast on spin echo images [64] and T2
* contrast on gra-
dient echo images [55]. The effect observed on gradient
echo images is much larger, since apart from dephasing
Fig. 5 Maps of Ki and T2
* at different time points (1 day–6 weeks)
after unilateral embolic stroke in a saline–treated control rat (C) and
in a sildenaﬁl-treated rat (T). In the control rat (ﬁrst row), Ki inside the
lesion was elevated from 1 week on, indicative of BBB disruption,
which peaked between 2 and 5 weeks after stroke. In a rat treated
with angiogenesis-promoting sildenaﬁl (second row), increase of Ki
was observed earlier and lasted shorter. Red arrows indicate
signiﬁcantly increased Ki values. In these presumably angiogenic
regions, T2
* values were signiﬁcantly decreased, at 4 or 2 weeks after
stroke in saline- (third row) and sildenaﬁl-treated rats (fourth row),
respectively. Red arrows indicate signiﬁcantly decreased T2
* values.
Reproduced from Ref. [33] with permission from Lippincott Williams
and Wilkins
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123due to diffusion through local magnetic ﬁeld gradients, all
static dephasing is refocused in spin echo images [40, 64].
Ding et al. have recently evaluated the potential of T2
*-
weighted imaging to identify angiogenesis in post-stroke
rat brain [33]. They observed a shorter T2
*, indicative of
more deoxygenated blood, in perilesional areas of placebo-
and sildenaﬁl-treated rats starting at 1 and 2 weeks after
stroke, respectively, which was hypothesized to arise from
maturing angiogenic venous structures. This was veriﬁed
with susceptibility weighted imaging, a variant of T2
*-
weighted MRI that includes phase information [65, 66],
which clearly enhanced the contrast of the areas with
increased magnetic susceptibility [33]. Furthermore,
regions exhibiting a decreased T2
* value spatially matched
with regions with high vascular permeability, based on Ki
measurements (Fig. 5). In another study from the same
group, T2
* shortening in the ischemic hemisphere corre-
sponded spatiotemporally with increasing CBF and tissue
fractional anisotropy, which would reﬂect a close rela-
tionship between angiogenesis and neuronal remodeling
[32] (Table 1).
Discussion and future perspectives
In the search for neuroprotective and neurorestorative
therapies aiming to improve functional outcome after
stroke, a better understanding of the endogenous processes
involved in spontaneous recovery after stroke is of major
importance. A healthy tissue perfusion status, responsible
for providing nutrients and oxygen and allowing clean-up
of waste products, is critical for mediating functional
recovery after brain injury. This process could be signiﬁ-
cantly augmented by vascular remodeling through angio-
genesis. Therefore, the prospect to noninvasively assess
physiological and structural characteristics of such events
would improve our knowledge on brain plasticity, and may
eventually help us to direct functional outcome of stroke to
our beneﬁt. This review illustrates how MRI can be applied
to noninvasively monitor the evolution of various post-
ischemic processes related to angiogenesis in the brain. The
presented studies demonstrate that MR imaging enables
assessment of a variety of (micro)vascular characteristics,
such as cerebral blood ﬂow and volume, vascular density
and vessel size, BBB integrity and blood oxygenation.
Despite its potential, we need to also be aware of several
pitfalls and limitations related to the application of MRI as
a tool for evaluating angiogenesis after stroke. For exam-
ple, an increase in Ki, i.e. contrast agent leakage, and
shortening of T2
*, i.e. more deoxygenated blood, which has
been found in relation to angiogenesis [33], may also arise
as a result of BBB disruption and hemorrhage in response
to vascular pathology [67]. Furthermore, MRI measure-
ments of tissue perfusion and microvascular characteristics
(CBF, CBV, Ki, MVD and VSI) rely on algorithms that are
based on relatively basic biophysical and mathematical
models that may be inaccurate under complex or altered
conditions, as is the case in stroke pathophysiology. The
methodological difﬁculties related to the models used in
DSC-MRI and ASL to quantify perfusion, especially under
abnormal ﬂow conditions, have been extensively reviewed
[21, 22, 68–70]. Furthermore, from a physiological point of
view, an increase in CBF and CBV, which has been
associated with post-stroke angiogenesis, may not be
exclusively speciﬁc to neovascularization, as vasodilatation
of existing vessels and collateral ﬂow may also contribute.
Hence, the combination of perfusion imaging with addi-
tional MR methods that provide information on micro-
vessel density and vessel size may help elucidating the
complex interdependence between CBF, CBV, MVD and
Table 1 MRI techniques, parameters, and contrast types and mechanisms to assess tissue characteristics related to vascular remodeling through
angiogenesis
MRI technique Parameter Contrast References
Physiological MRI Mechanism Type
Angiography Vascular anatomy – Tracer inﬂow Endogenous/
exogenous
[20]
DSC-MRI CBF DR2
* Dv, contrast passage Exogenous [17, 18, 32, 52, 78]
CBV
ASL CBF Magnetically labeled
arterial water
Tracer inﬂow Endogenous [18, 32, 33, 78]
ssCE-MRI BVftotal DR2
* Dv, pre- and post-contrast Exogenous [45, 46]
BVfmicrovascular DR2 [43]
Vessel size DR2
*/DR2 [34, 44–48]
Vessel density DR2/(DR2
*)
2/3 [49–52]
DCE-MRI BBB permeability Ki T1, pre- and post-contrast Exogenous [16, 17, 27, 33, 52, 54, 57–61]
BOLD Oxygenation DR2, DR2
* Dv, deoxyHb Endogenous [33, 55, 64, 79]
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123VSI. This can be accomplished with ssCE-MRI, as dis-
cussed in this review. Theoretical modeling as well as
Monte Carlo simulations have demonstrated the ability to
quantify MVD and VSI with ssCE-MRI [34, 42, 44, 48,
49], however, in practice MVD and VSI are typically
qualitatively expressed [47, 52]. Quantiﬁcation of micro-
vessel density and size based on in vivo MRI measure-
ments have been reported based on assumptions of the
diffusion coefﬁcient D and susceptibility difference Dv [50,
51]. Since D may considerably change under speciﬁc
pathological conditions, and post-contrast Dv will vary
between subjects, it can be expected that deﬁning D and Dv
based on literature values will affect the accuracy of
quantitative MVD and VSI measurements. In addition,
large variations of Q values, as well as DR2
*/DR2 ratios,
have been reported for rat brain [44, 48–52], which may be
explained by additional biophysical assumptions and gen-
eralizations. First, the vascular network is assumed to
consist of randomly oriented straight cylinders, ignoring
the inﬂuence of curvature. Second, the vessel diameter
within tissue-of-interest is often approximated at a single
diameter. Third, isotropic diffusion is assumed. Fourth,
computations rely on an intact BBB. Obviously, variations
and alterations in these factors can lead to under- or
overestimation of MVD and VSI calculations. Elucidation
of the inﬂuence of these aspects in ssCE-MRI is critical for
adequate use of this promising approach in assessing vas-
cular characteristics in healthy and pathological brain.
A promising new MRI approach that may enable direct
detectionofangiogenesisismolecularimagingwithcontrast
agents that are targeted to speciﬁc molecular markers of
vascular remodeling. In oncology, MR-based molecular
imaging with amb3-integrin-targeted paramagnetic nano-
particles has already demonstrated its potential to monitor
tumor angiogenesis [71–73]. A clear example of the poten-
tialofinvivomolecularimagingofangiogenesisafterstroke
has recently been presented by Cai et al., who used positron
emission tomography (PET) to measure upregulation of
VEGF receptors with radioactively-labeled VEGF in the
ischemicratbrain.Fornoninvasivemonitoringofkineticsof
expression of molecular markers, nuclear imaging tech-
niquesarevaluable,however,theirrelativelylowresolution,
requirement of a radioactive tracer and lack of anatomical
reference, are signiﬁcant drawbacks that may be overcome
by development of MR-based molecular imaging. A
potential innovative way to monitor the onset of vascular
remodeling in a very early stage with MRI, may be
accomplished with MR reporter genes, which allow nonin-
vasive assessment of expression of a gene of interest toge-
ther with synthesis of an MR detectable by-product, such as
endogenous paramagnetic ferritin [74–76].
In conclusion, in this review we have presented recent
developments in the ﬁeld of MR imaging that enable in
vivo assessment of different physiological parameters,
e.g. tissue perfusion and microvascular morphology, that
can shed light on various aspects related to angiogenesis
after stroke. These developments may provide important
new insights into the role of vascular remodeling in brain
plasticity and functional recovery after stroke, and may
be valuable for monitoring of possible future therapies
designed to promote (neo)vascularization in stroke
patients.
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